Marina Noeva-Panova

Untere Zahlbacher Str. 8
Mainz, RP 55131, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Proteomic patterns according to ejection fraction: an EMPEROR-programme analysis.

Proteomic patterns according to ejection fraction: an EMPEROR-programme analysis.

Journal: European journal of heart failure

Published: July 24, 2025

Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR Program.

Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR Program.

Journal: European journal of heart failure

Published: April 17, 2025

Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: The EMPEROR Program.

Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: The EMPEROR Program.

Journal: Journal of the American College of Cardiology

Published: January 09, 2025

Author Correction: Subclassification of obesity for precision prediction of cardiometabolic diseases.

Author Correction: Subclassification of obesity for precision prediction of cardiometabolic diseases.

Journal: Nature medicine

Published: November 21, 2024

Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Patients With Heart Failure: A Validation Cohort of the EMPEROR Program.

Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Patients With Heart Failure: A Validation Cohort of the EMPEROR Program.

Journal: Journal of the American College of Cardiology

Published: June 10, 2024

BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study.

BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study.

Journal: Cardiovascular diabetology

Published: March 15, 2024

Subclassification of obesity for precision prediction of cardiometabolic diseases.

Subclassification of obesity for precision prediction of cardiometabolic diseases.

Journal: Nature medicine

Published: March 08, 2024

Cardiovascular and genetic determinants of platelet high responsiveness: results from the Gutenberg Health Study.

Cardiovascular and genetic determinants of platelet high responsiveness: results from the Gutenberg Health Study.

Journal: Blood advances

Published: December 28, 2023

Obesity-related inflammatory protein signature in cardiovascular clinical outcomes: results from the Gutenberg Health Study.

Obesity-related inflammatory protein signature in cardiovascular clinical outcomes: results from the Gutenberg Health Study.

Journal: Obesity (Silver Spring, Md.)

Published: December 04, 2023

Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme.

Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme.

Journal: European journal of heart failure

Published: November 05, 2023

Stratification of obesity phenotypes to optimize future therapy (SOPHIA).

Stratification of obesity phenotypes to optimize future therapy (SOPHIA).

Journal: Expert review of gastroenterology & hepatology

Published: October 04, 2023

Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.

Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.

Journal: European journal of heart failure

Published: September 20, 2023

Showing 1-12 of 64

Last Updated: 09/26/2026